You are here

Ogawa-Yamanaka Stem Cell Prize

The Ogawa-Yamanaka Stem Cell Prize recognizes individuals whose original translational research has advanced cellular reprogramming technology for regenerative medicine. The prize was established in 2015 through a generous gift from Hiro and Betty Ogawa and is supported by the Gladstone Institutes. Winners receive an unrestricted prize of $150,000. Nomination information.

The Ogawa-Yamanaka Stem Cell laureate(s) will be honored at an event including a scientific presentation at the Gladstone Institutes in San Francisco, California.


2016 Douglas Melton, PhD
Co-director of the Harvard Stem Cell Institute,
The Xander University Professor at Harvard University,
Investigator of the Howard Hughes Medical Institute
Melton was honored for his work to treat diabetes with insulin-producing pancreatic cells created from stem cells.
2015 Masayo Takahashi, MD, PhD
Project Leader, Laboratory for Retinal Regeneration at the RIKEN Centre for Developmental Biology
Takahashi was honored for being the first to use induced pluripotent stem cells in a clinical trial


Selection Committee

George Daley, MD, PhD
Professor of Hematology/Oncology
Director, Stem Cell Transplantation Program
Boston Children’s Hospital

Hideyuki Okano, MD, PhD
Professor, Department of Physiology
Chairman, Graduate School of Medicine
Keio University

Deepak Srivastava, MD
Director, Gladstone Institute of Cardiovascular Disease
Director, Roddenberry Center for Stem Cell Biology and Medicine
Gladstone Institutes

Marius Wernig, MD
Associate Professor
Stanford Institute for Stem Cell Biology and Regenerative Medicine

Shinya Yamanaka, MD, PhD
Senior Investigator
Gladstone Institutes and
Kyoto University


Ogawa-Yamanaka Prize

Deepak Srivastava, Hiro Ogawa, Masayo Takahashi, Shinya Yamanaka, and Sandy Williams celebrate the inaugural Ogawa-Yamanaka Stem Cell Prize. [Photo: Chris Goodfellow]


Nominations for the 2017 prize are now open. Click below to access nomination criteria and online form.


Online Nomination

The Gladstone Institutes is pleased to present the second annual Ogawa-Yamanaka Stem Cell Prize to Douglas Melton, PhD for his research on the genetic markers expressed during pancreas development that led to a reliable way to reprogram stem cells into human beta cells. His work provides the foundation for the ultimate goal of transplantable, patient-specific beta cells.
Read story

The inaugural Ogawa-Yamanaka Stem Cell Prize was awarded to Masayo Takahashi, MD, PhD for her trailblazing work leading the first clinical trial to use induced pluripotent stem (iPS) cells in humans.

Read story